Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.220
-0.040 (-0.94%)
At close: Feb 21, 2025, 4:00 PM
4.320
+0.100 (2.37%)
After-hours: Feb 21, 2025, 4:41 PM EST
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Voyager Therapeutics stock have an average target of 15.53, with a low estimate of 5.73 and a high estimate of 30. The average target predicts an increase of 268.01% from the current stock price of 4.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Voyager Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 5 | 5 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +610.90% | Jan 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $5.73 | Buy | Initiates | $5.73 | +35.78% | Jan 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +184.36% | Dec 2, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +231.75% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +610.90% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
92.10M
from 250.01M
Decreased by -63.16%
Revenue Next Year
69.60M
from 92.10M
Decreased by -24.43%
EPS This Year
-0.94
from 2.97
EPS Next Year
-1.63
from -0.94
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 103.7M | 151.2M | 154.3M | |||
| Avg | 92.1M | 69.6M | 85.9M | |||
| Low | 77.1M | 3.9M | 19.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -58.5% | 64.2% | 121.7% | |||
| Avg | -63.2% | -24.4% | 23.5% | |||
| Low | -69.2% | -95.7% | -71.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.69 | -0.66 | -0.51 | |||
| Avg | -0.94 | -1.63 | -1.28 | |||
| Low | -1.15 | -3.02 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.